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Abstract 
 
Aneuploidy seems to play not only a decisive role in embryonal development but also in 
tumorigenesis where chromosomal and genomic instability reflects a universal feature of 
malignant tumors. The cost of whole genome sequencing has fallen significantly, but it is still 
prohibitive for many institutions and clinical settings. No applied, cost-effective and efficient 
technique has been introduced yet aiming at research to assess the ploidy status of all 24 
different human chromosomes in interphases simultaneously, especially in single cells. 
Here we present the selection of human probe DNA and a technique using multi-step FISH 
employing four sets of six labelled FISH probes able to delineate all 24 human chromosomes 
in interphase cells. This full karyotype analysis approach will provide additional diagnostic 
potential for single cell analysis. The use of spectral imaging (SIm) has enabled the use of up 
to eight different fluorochrome labels simultaneously. Thus, scoring can be easily assessed 
by visual inspection, since SIm permits computer-assigned and distinguishable pseudo-
colors to each probe during image processing. This enables full karyotype analysis by FISH of 
single cell interphase nuclei. 
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Introduction 
Evaluating numerical abnormalities and structural aberrations of chromosomes by 
fluorescence in situ hybridization (FISH) has been extensively carried out on cell metaphases 
and interphases since this technique has been introduced in the mid-1980s.1 Methodologies 
such as spectral karyotyping (SKY)2 or multiplex FISH3 and also comparative genomic 
hybridization (CGH)4 were able to effectively evaluate cytogenetic damage on metaphases 
across the whole genome. Nowadays, modern techniques like high-resolution chip-based 
CGH arrays and next-generation sequencing (NGS), in particular massive parallel sequencing 
(MPS), are capable of evaluating a plethora of cytogenetic changes. For array CGH, 
segmental DNA copy number variations at kilobase-pair resolution can be detected;5 while 
MPS is capable to analyze large parts of the genome by using shallow or low-pass whole 
genome sequencing when no coverage of the full genome is required, e.g. for 
preimplantation genetic diagnosis (PGD).6  
 
In the early 2000s implantation rates had improved due to PGD aneuploidy screening by 
using commercially available chromosomal probe sets for single-cell analysis allowing the 
enumeration of up to ten chromosomes with fluorescence filter-based evaluation. Thereby, 
more than half of the numerical abnormalities seen in abnormal embryos originating from 
non-disjunction of chromosomes during cell division were covered.7-10 Without a doubt, 
aneuploidy is the most common cause of chromosomal abnormalities in humans leading to 
pregnancy loss.11, 12 Hence, shifting from partial karyotype FISH analysis to genome 
sequencing in the last decade allowed for simultaneous testing of numerous genetic 
aberrations and abnormalities. This was also evident when looking at the biopsied 
specimens, shifting away from polar bodies or blastomeres towards the trophectoderm.13 In 
human embryos, multiple molecular mechanisms that may also be involved in cancer 
formation can lead to aneuploidy and chromosomal mosaicism, thus to negative pregnancy 
outcomes; however, low-level mosaicism in human development may be a normal feature 
after all.14  
Aneuploidy seems to also play a crucial role in cells of the extra-embryonal tissue that are 
important in implantation during early pregnancy and the formation of the placenta. These 
so-called invasive cytotrophoblasts (iCTBs) showed different aneuploidy levels on the basis 
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of their invasive behavior when assessed by using spectral imaging targeting six different 
chromosomes.15 
Aneuploidy seems to play not only a decisive role in embryonal development but also in 
tumorigenesis where chromosomal and genomic instability reflects a universal feature of 
malignant tumors.16 It seems that the primary cause of pre-neoplastic / neoplastic genomic 
instability is the progression from stable diploid cells to unstable aneuploid cell species17 
making aneuploidy a useful marker of malignant transformation.18 
 
Although the cost for sequencing the whole genome has fallen to around $1,000 per 
analyzed genome19 the price tag for equipment and material is quite high.20 Even though 
larger hospital trusts, major universities and private biotech companies may have the funds 
to carry out high-throughput array chip methods and NGS on a daily basis, no applied, cost-
effective and efficient technique has been introduced yet aiming at research to assess the 
ploidy status of all 24 different human chromosomes in interphases simultaneously, 
especially in single cells.  Improving the coverage of all the chromosomes and devising 
sophisticated, fast and reliable methods to evaluate these single cells is favorable as not all 
of the possible numerical abnormalities can be currently assessed due to the limited 
number of available chromosome-specific probes and the limited number of suitable 
fluorochromes.21, 22  
 
Here we present the selection of human probe DNA and a technique using multi-step FISH 
employing four sets of six labelled FISH probes able to delineate all 24 human chromosomes 
in interphase cells. This full karyotype analysis approach will provide additional diagnostic 
potential for single cell analysis. 
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Material and Methods 
Clone selection and DNA preparation 
BAC clones23 from the RP11 library (Invitrogen, Gaithersburg, MD) were chosen based on 
information available from the UC Santa Cruz (UCSC) genome sequence database 
(http://genome.ucsc.edu/cgi-bin/hgGateway) and the U.S. National Institute of Health, 
National Center for Biotechnology Information (NIH/NCBI) 
(http://www.ncbi.nlm.nih.gov/mapview/map_search.cgi?taxid=9606). Comprehensive DNA 
sequence information as well as structural organization of these BACs can be found in the 
above-mentioned databases. The preparation of DNA from BAC clones has been described 
in detail before.24 Briefly, clones were cultured overnight in 10 ml Luria-Bertani (LB) medium 
containing 12.5 µg/ml chloramphenicol (Sigma, St. Louis, MO) and DNA was isolated using 
an alkaline lysis DNA extraction protocol.25 In addition to BAC clones (see Table 1 for a 
complete overview) bacterial plasmid clones from the Weier lab at the LBL have been used. 
For the isolation of plasmids from clones RMC16L00626, pBS444/7, pBS864, pBS1131, 
pBS8B/9, pBS239’-5’, pBS609/51, 680TA-4 and W21R2-TA13 a commercial Kit from Qiagen 
was used on an overnight LB culture containing 30 µg/ml ampicillin (RMC and pBS clones) or 
kanamycin (TA clones), respectively. Except for the RMC16L006 plasmid DNA, all other 
plasmid DNA has been employed as templates in PCR reactions. The final probe sets can be 
seen in Table 2. 
 
For PCR, 100 ng genomic DNA (Sigma), BAC or plasmid DNA was used as template for DNA 
amplification. PCR reactions (50 μl) were performed using 0.02 U/ml Taq Polymerase 
(Invitrogen) or JumpStart Taq polymerase (Sigma) in 1x PCR buffer (Invitrogen), 1.5 mM 
MgCl2, 0.2 mM of each dNTP, and 0.6 mM of the forward and reverse primers (Qiagen; 
Alameda, CA). The chromosomes 1 and 6 alpha-satellite primers have been used as 
described previously.27 The generation of chromosome 17 and 18 specific probes has also 
been previously published.28 BlueScript primers WBS2 (ctc gga att aac cct cac taa agg) and 
WBS4 (gaa ttg taa tac gac tca cta tag) for the DNA amplification of alpha-satellite repeats 
were employed for chromosomes 8, 10, and 12. For chromosome 7 and 11, primers M13F / 
M13R29 and WA8 (gat ggt agt agg ca[a/t] [c/g]t[c/a] aca gag) / WA9 (gat ggt agt agg cat 
c[a/c]c [a/c]aa g[a/t/c]a), respectively, have been used to amplify chromosome-specific 
DNA. For the amplification of chromosome 9 and 21 specific probe DNA a single primer was 
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in use for both, the satellite III primer W21R2 (caa acg tgc tca aag taa ggg aat g) and Jun15 
(ccc aag ctt gca tgc gaa ttc), respectively. After an initial denaturation step of 2 min at 95 °C, 
35 PCR cycles followed: denaturation at 95 °C for 40 sec, primer annealing at 54 °C for 1 min, 
and primer extension at 72 °C for 2.5 min. Ramp time was set to 30 sec for the first step 
followed by 1 min for the next two steps. A final step at 72 °C for 10 min concluded the PCR. 
PCR products were confirmed on a 2% agarose gel by applying 5 μl of the PCR reaction 
mixed with 1 μl of 0.4 g/ml sucrose solution.  
 
DNA labeling and FISH 
Using a commercially available kit (BioPrime Kit, Invitrogen, Gaithersburg, MD), random 
priming was employed to label all the BAC, plasmid and PCR-derived probe DNA. After initial 
testing employing indirect labels;30-32 the random priming process was slightly modified to 
incorporate various fluorochrome dUTPs into the probe DNA: Cy5-dUTP and Cy5.5-dCTP 
(Amersham, Arlington Heights, IN), DEAC-dUTP (PerkinElmer, Waltham, MA) as well as 
SpectrumGreen-dUTP, SpectrumRed-dUTP and SpectrumOrange-dUTP (Vysis, Abbott 
Molecular Inc, Des Plaines, IL). Regarding the four sets of chromosome-specific probes, 
Table 2 gives also an overview of their direct fluorescent labels. 
 
 
For FISH, labeled probe DNA is mixed with blocking DNA and concentrated via precipitation 
in ethanol. Salmon sperm DNA is added to block non-specific binding of the probe, and 
human COT1 DNA is added to block repetitive DNA sequences in the probes from binding to 
sites spread throughout several chromosomes/loci. The desired combination of labeled 
probe is mixed using 2-5 μl of each individual probe, depending on intensity of signal, as 
previously described.15 
This is then combined with 1 μl of human Cot-1 DNA® (1 mg/ml, Invitrogen), 1 μl of salmon 
sperm DNA (10 mg/ml; Invitrogen), and 7 μl of the hybridization master mix (78.6% 
formamide, 14.3% dextran sulfate in 1.43x SSC, pH 7.0; 20x SSC is 3 M sodium chloride, 300 
mM tri-sodium citrate) and thoroughly mixed and denatured at 76 °C for 10 min. The 
hybridization mixture was then pre-annealed by incubating at 37 °C for 30 min (allowing the 
Cot-1 DNA® to anneal to non-chromosome specific DNA repeats on the probes). In parallel, 
the metaphase slides prepared from phytohemagglutinin (PHA)-stimulated peripheral blood 
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lymphocytes from a karyotypically normal male31 were denatured for 3 min at 76 °C in 70% 
formamide/2x SSC, pH 7.0, dehydrated in 70%, 85%, and 100% ethanol for 2 min each, and 
allowed to air-dry. The hybridization mixture was then carefully applied to the slides, 
covered with a 22x22 mm2 cover-slip and sealed with rubber cement. Slides were incubated 
overnight in a moist chamber at 37 °C. After removing rubber cement and the cover-slips, 
the slides were washed in 0.1x SSC at 43°C for 2 min, then, when biotin or digoxigenin labels 
have been used, incubated in PNM blocking reagent (5% nonfat dry milk powder (NESTLÉ 
Carnation, Wilkes-Barre, PA), 1% Nonidet-P40 (Sigma), 1% sodium azide (Sigma), 0.1 M 
sodium phosphate buffer, pH 8.0) for 10 min at room temperature. Bound probes were 
detected with fluorescein-conjugated avidin (avidin DCS, Vector labs, Burlingame, CA) and 
rhodamine-labeled anti-digoxigenin antibodies (Roche Diagnostics, Indianapolis, IN). In the 
case of direct-labeled probes, no immuno-detection step was necessary. Finally, after a last 
wash in PN or 2xSSC the slides were mounted with 4’,6-diamidino-2-phenylindole (DAPI, 0.5 
µg/ml; Calbiochem, La Jolla, CA) in antifade solution.32, 33 
 
Image acquisition and analysis 
Fluorescence microscopy was performed on a Zeiss Axioskop microscope equipped with a 
SKY filter set (ChromaTechnology, Brattleboro, VT) for simultaneous observation of SKY 
suitable fluorochromes and also a DAPI filter (ChromaTechnology, Brattleboro, VT) for the 
detection of the counter stain. Images were collected using a cooled CCD camera (CCD-
1300DS, VDS Vosskuehler, Osnabrück, Germany).24 Further processing and printing of the 
images were done using the image processing software Adobe Photoshop (Adobe Systems 
Inc., San Jose, CA). 
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Results 
Our probe sets have been constructed by choosing the most suitable probe DNA and 
fluorochrome so that each chromosome-specific probe within its set provides specificity and 
similar high efficiency. The probes used (see Tables 1 and 2 for a complete overview) are 
either locus-specific or repeat-specific (targeting alpha-satellites or satellite III). They are 
labeled with the following fluorescent labels: DEAC (excitation wavelength: 432 nm / 
emission wavelength: 472 nm, light blue), SpectrumGreen (497 nm / 524 nm, greens), 
SpectrumOrange (559 nm / 588 nm, orange), SpectrumRed (592 nm / 612 nm, red), Cy5 
(649 nm / 666 & 670 nm, infrared), and Cy5.5 (675 nm / 694 nm, infrared). 
 
Sets I and II detect chromosomes 13, 14, 16, 20, 21, and 22 as well as of chromosomes 15, 
17, 18, 19, X, and Y, respectively (Figure 1) according to their fluorochrome labels (Figure 2), 
whereas sets III and IV are able to evaluate the rest of the chromosomes for the full 
karyotype by detecting chromosomes 2, 3, 4, 5, 9, and 12 as well as chromosomes 1, 6, 7, 8, 
10, and 11, respectively (Figure 3). All the signals produced in metaphases and interphases 
by FISH are unambiguous, strong and do not cross-hybridize to other chromosomes (Figures 
1 and 3). The exception was chromosome 9 in set III (Figure 3) which did produce a strong 
signal when tested for itself but was rather dim when co-hybridized with the rest of set III 
probes. 
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Discussion 
Detection techniques for assessing numerical abnormalities and other cytogenetic 
aberrations often utilizes cost-effective and rapid classical staining methods such as Giemsa 
staining for karyotyping, but also molecular diagnostic tools like FISH and its multiple 
variations for a quick, robust and reliable detection of genetic damage. During the last 
decade, methodology development has been progressing towards a full karyotype 
analysis;34 however, adjusting probe sets, i.e. probe target and fluorochrome label, rapidly 
to particular needs in the laboratory is still quite difficult. Using BAC clones as a source of 
probe DNA for FISH is cheap and effective28, 35, 36 on the other hand allows the analysis of 
the whole genome37, 38 for cytogenetic diagnoses. However, this metaphase-specific 
approach cannot be used for analysis of a single cells per se, as they are likely to be in an 
interphase stage.  
 
While several bright chromosome-specific DNA repeat probes have been prepared and 
cloned by our labs in previous years,30, 39 the approach does not work for all human 
chromosomes. The acrocentric chromosomes 13 and 21, for example, share a high level 
homologous of sequences which is found heteromorphic in some individuals.40 The BAC 
approach41 has advantages for complete chromosome enumeration in interphase cells. 
During preparation of this manuscript, Ioannou et al. demonstrated this using BAC clones 
from Roswell Park Cancer Institute RP-11 library. We decided to combine preexisting DNA 
repeat probes with optimized BAC contigs which identified using bioinformatics22, 42 to 
obtain optimal specificity and brightness (Table 2).  
Now, combining the versatility of BACs and preexisting repeat probes with a wide repertoire 
of different fluorochromes together with the use of the SKY system resulted in a cost-
effective, flexible and reliable methodology to detect four sets of six probes in interphase 
nuclei (see Figures 1 and 3). Incorporating consecutive hybridization steps (cell recycling) 
considerably increased the diagnostic range of existing FISH technologies.43  
 
Sequential multi-locus interphase FISH is one strategy where chromosome specific (locus-
specific and alpha-centromeric) FISH probes have been hybridized sequentially to the same 
cell, initially done in formalin fixed and paraffin embedded histological sections from tumor 
tissues.44 The use of spectral imaging (SIm) has enabled the use of up to eight different 
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fluorochrome labels (with emission spectra from 450-1000 nm) simultaneously.45 The 
scoring can be easily assessed by visual inspection, since SIm permits computer-assigned 
and distinguishable pseudo-colors to each probe during image processing.2 This lead to the 
full karyotype analysis by FISH of single cell interphase nuclei like those of iCTBs in placental 
cell analysis (data not shown in this publication).  
The benefits of combing sets of single copy DNA probes with separate sets of DNA repeat 
probes that contain super-bright signals in sequential hybridizations may raise concerns of 
DNA loss in repeated cycles of denaturation, hybridization and wash steps. The approach 
presented here does not eliminate potential problems associated with DNA losses, but 
optimized BAC contigs and plasmids targeting highly reiterated DNA repeat sequences 
consistently leads to brighter signals, thus reducing the negative effect of said losses. 
 
As seen in Figure 3, the flexibility of choosing probe DNA and fluorochromes may have an 
unforeseen negative consequence, chromosome 9 showed a very dim signal which was 
below the threshold of detection for the SKY system, even though the same probe resulted 
in good strong signals when tested individually. Hence, either cell-type or donor differences 
as well as the interaction of DNA probes with each other within a set could lead to a less 
prominent of even a very dim and almost not visible signal. Thus, quality control when 
tailoring such probe sets to work in particular cell types is imperative. 
 
In this publication, we presented the development of a probe collection made up of four 
sets of six labeled chromosome-specific FISH probes which can easily be modified towards 
three sets of eight probes using far-infrared fluorochromes like Cy7. These have been 
arranged so that the first two sets detect the most prevalent numerical abnormalities 
observed in human embryos, and the last two sets fill in the gap towards a full karyotype 
analysis. The generation of these probe sets shows the full potential of BAC/plasmid clones, 
which can be rapidly selected and tailored for specific genetic screening applications. The 
strong signal intensities from these repeat-rich probes and the labeling methodology 
employed, allows reduction in the costs for a single hybridization event by approximately 
10-fold over conventional FISH.  
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In a clinical PGD setting, there is no apparent reason to do further analysis using multiple 
FISH probe sets after determining an abnormal ploidy status such as trisomy 13; however, if 
information on all 24 different chromosomes for individual embryos, i.e. the discarded 
chromosomally abnormal embryos, can be collected, this could be very important 
information for early embryo development, and this information may be useful for future 
clinical diagnosis. Also, with regard to array and NGS analysis in a clinical PGD setting, 250-
500 ng of DNA, an equivalent of about 35,000-70,000 cells, would be required for analysis. 
This entails that if there is only a limited number of cells (i.e. blastocytes) whole genome 
amplification will have to be applied increasing time and cost but also errors.46 As our 24-
probe set was originally developed for and applied to score all 24 chromosomes in placental 
invasive cytotrophoblasts (CTBs), we have found that at least 75% of the male invasive CTBs 
have gained extra copies of chromosomes with the most common gains being acrocentric 
chromosomes. Also, most of the invasive CTBs did not have the same karyotype 
(unpublished data). The probes that have been developed and tested are typically very 
useful to do full karyotyping on the few interphase cells, such as cancer stem cells, fetal cells 
in maternal blood, or heterogeneous cells with different karyotypes. 
 
The set of 4x6 chromosome enumerating FISH probes has been initially developed in-house 
to study invasive placental cells and to aid in PGD due to the fact that only some commercial 
probes are available as enumeration sets with a maximum of four different colors. There are 
many clinical applications for DNA probe sets like the ones described here, i.e. prenatal 
analysis of aneuploidy. But for example, if one wishes to study malignant mesothelioma, the 
panel would include a probe for ERBB2.47  Similarly, overexpression due to potential 
amplifications of the epidermal growth factor receptor (EGFR) gene in squamous carcinoma 
cell lines might include an EGF receptor-specific DNA probe.48 Hence, it is very conceivable 
that our set of probes, original or modified, could find a use in other studies, such as in 
tumor cytogenetic evaluations or chromosome analysis in genotoxicology and mutagenesis, 
or whenever quick chromosome analysis of numerical abnormalities in interphase cells is 
required.  
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Table legends 
 
Table 1 legend 
Table 1 shows a complete overview of BAC clones and bacterial plasmid clones used. 
 
 
Table 2 legend 
Table 2 shows the final probe set used. 
It also gives an overview of the direct fluorescent labels for the four sets of chromosome-
specific probes. 
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Table 1 
 
Locus Probe name Clones/DNA End sequence 1 End sequence 2  Full sequence ID 
13q21.31 OR7E156P RP11-527N12  -  - AL354810 
  RP11-282D7  -  - AL355609 
  RP11-320N6  -  - AL359208 
  RP11-67L17  -  - AL354774 
  RP11-473M10  -  - AL445989 
  RP11-394A14  -  - AL445238 
  RP11-520F9  -  - AL355879 
  RP11-205B18  -  - AL354736 
14q13.3 PAX9 RP11-12H15 B75808 B75809  - 
  RP11-150O18 AQ378665 AQ378667  - 
  RP11-452H6 AQ583099 AQ583102  - 
  RP11-381L10 AQ532441 AQ554647  - 
  RP11-73H19 AQ266602 AQ266604  - 
  RP11-49P15 AQ051953 AQ051955  - 
  RP11-151J2 AQ379285 AQ379286  - 
  RP11-410J4 AQ549717  -  - 
16qh, sat II RMC16L006 RMC16L006  -  - X06138 
20p11.1-11.2 SRCext RP11-298O1 AQ507400 AQ507403  - 
  RP11-465M13 AQ636482  -  - 
  RP11-192N1 AQ412321 AQ412322  - 
  RP11-151C5 AQ376308 AQ376305  - 
  RP11-451G10 AQ583252 AQ583256  - 
  RP11-103B19 AQ313159 AQ313162  - 
  RP11-467A7 AQ637700 AZ516714  - 
  RP11-99B19 AQ318386 AQ318387  - 
  RP11-76O8 AQ266982 AQ266948  - 
21q22 D21S167 YAC 141G6  -  - X52289 
22q11.22-q11.23 BCR RP11-357H16 AZ518881 AQ553050  - 
  RP11-62K15 AQ199674 AQ199676  - 
  RP11-164N13 AQ380113 AQ380117  - 
15q25.3 NTRK3ext RP11-116G21 AQ348695 AQ348692  - 
  RP11-113C11 AQ344985 AQ344986  - 
  RP11-96B23 AQ313684 AQ313681  - 
  RP11-114I9 AQ344858 AQ344856  - 
  RP11-285I14  -  - AC011966 
  RP11-427O16  -  - AC023844 
  RP11-356B18  -  - AC009711 
  RP11-247E14  -  - AC087593 
  RP11-97O12  -  - AC013489 
17cen, α-sat 17cen RP11-285M22  -  - AC131274 
18cen, α-sat 18cen genomic DNA  -  - M65181 
19q13.2 AXL CTD-2052L21 AQ270406 AQ235108  - 
  CTD-2288H11 B98832  -  - 
  CTD-2195C23  -  -  - 
  CTD-2017C04  -  -  - 
  CTD-2195B23  -  - AC011510 
  CTD-2218D21 AQ032786  -  - 
Xq21 CYCL1 RP11-422C9 AQ553389 AQ553391  - 
  RP11-475A12 AQ635998 AQ636000  - 
  RP11-14A18 B76225 B82244  - 
Yq12 RP11-242E13 RP11-242E13  -  - AC068123 
1cen, α-sat 1cen genomic DNA  -  -  - 
2p16.1-15 RELext RP11-65A9 AQ237129 AQ237131  - 
  RP11-139C21 AQ382574 AQ382578  - 
  RP11-71D7 AQ236987 AQ267891  - 
  RP11-373L24  -  - AC010733 
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  RP11-375M18 AQ533441 AQ551245  - 
  RP11-418N22 AQ550069 AQ550072  - 
  RP11-77P21 AQ284573 AQ284575  - 
  RP11-477N2 AQ637330 AQ637326  - 
  RP11-143D11  -  - AC092103 
3q27.3 BCL6 RP11-567G11  -  - AC104635 
  RP11-88P6  -  - AC018919 
  RP11-211G3  -  - AC072022 
  RP11-58M14 AQ199229 AQ199231  - 
  RP11-120O8 AQ350519 AQ350515  - 
  RP11-1E24 B48349 AQ312932  - 
4q22.1 TIGD2ext RP11-502A23  -  - AC079141 
  RP11-84C13  -  - AC104785 
  RP11-173C9  -  - AC105388 
  RP11-549C16  -  - AC093862 
  RP11-15F14 B76416 B76417  - 
  RP11-115D19  -  - AC097478 
  RP11-67M1  -  - AC093759 
  RP11-350B19  -  - AC105445 
  RP11-176N15  -  - AC108038 
  RP11-183D16  -  - AC093781 
5q23.1 05BP1-S47 RP11-23E11 B86433 B86434  - 
  RP11-254M1 AQ479016 AQ479018  - 
  RP11-464H3 AQ586366 AZ515952  - 
  RP11-133L2 AQ350910 AQ350911  - 
  RP11-59G17 AQ194868 AQ194864  - 
  RP11-42O22 AQ116158 AQ046673  - 
  RP11-185N19  -  - AC021224 
12cen, α-sat 12cen 444/7  -  - G03348 
6cen, α-sat 6cen 864  -  - G04505 
7cen, α-sat 7cen 680TA-4  -  - AJ295152 
8cen, α-sat 8cen 8B/9  -  - M64779 
9cen, sat III 9cen W21R2-TA13  -  - X06137 
10cen, α-sat 10cen 609/51  -  - X63622 
11cen, α-sat 11cen 238'-5'  -  - M21452 
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Table 2 
 
Set Locus Position (Mbp) Probe type Label Color Clone/Contig ID 
I 13q21.31 62.520-63.638 BAC pool of 8 BACs Cy5 IR1 OR7E156P 
I 14q13.3 35.678-36.975 BAC pool of 8 BACs DEAC aqua PAX9 
I 16qh, sat II  - Plasmid Cy5.5 IR2 RMC16L006 
I 20q11.1-11.2 34.950-36.152 BAC pool of 9 BACs Sp.Red red SRCext 
I 21q22 around 37.770 PCR product Sp.Green green D21S167 
I 22q11.22/23 21.545-22.085 BAC pool of 3 BACs Sp.Orange orange BCR 
II 15q25.3-26.1 85.745-86.975 BAC pool of 7 BACs Sp.Orange orange NTRK3ext 
II 17cen, α-sat  - PCR product Sp.Red red 17cen 
II 18cen, α-sat  - PCR product Cy5.5 IR2 18cen 
II 19q13.2 around 46.500 BAC pool of 6 BACs Sp.Green green AXL 
II Xq21 82.447-82.915 BAC pool of 3 BACs Cy5 IR1 CYCL1 
II Yq12 57.158-57.256 Single BAC DEAC aqua RP11-242E13 
III 2p16.1-15 60.525-61-831 BAC pool of 9 BACs Sp.Red red RELext 
III 3q27.3 188.590-188.976 BAC pool of 6 BACs Sp.Green green BCL6 
III 4q22.1 90.168-91.675 BAC pool of 10 BACs Sp.Orange orange TIGD2ext 
III 5q23.1 116.279-117.541 BAC pool of 7 BACs DEAC aqua 05BP1-S47 
III 9cen, sat III  - PCR product Cy5.5 IR2 9cen 
III 12cen, α-sat  - PCR product Cy5 IR1 12cen 
IV 1cen, α-sat  - PCR product Cy5.5 IR2 1cen 
IV 6cen, α-sat  - PCR product Sp.Green green 6cen 
IV 7cen, α-sat  - PCR product Sp.Red red 7cen 
IV 8cen, α-sat  - PCR product DEAC aqua 8cen 
IV 10cen, α-sat  - PCR product Sp.Orange red 10cen 
IV 11cen, α-sat  - PCR product Cy5 IR1 11cen 
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Figure legends 
 
Figure 1 
(A) FISH probe set I (see Table 2) hybridized on one metaphase spread from normal male 
lymphocyte and (B) one interphase nucleus. Computer assigned pseudo-colors can be seen 
showing two copies each of chromosomes 13, 14, 16, 20, 21, and 22. (C) FISH probe set II 
(see Table 2) hybridized on one metaphase spread from normal male lymphocyte and (D) 
one interphase nucleus. It showed two copies each of chromosomes 15, 17, 18, 19, and one 
copy of chromosome X and Y.  The size bars on panels A and C indicate 5 µm while those on 
panels B and D indicate 2.5 µm.   
 
Figure 2 
(A) The emission spectra of DEAC, Spectrum Green, Spectrum Orange, Spectrum Red, Cy5, 
and Cy5.5 can be seen in this graph. (B) By using the distinguished emission spectra of these 
fluorochromes saved in a classified file the SKY system can easily identify individual 
chromosomes and create a karyotype. This is an example of an abnormal female cell 
hybridized with probe set II showing four copies each of chromosomes 15 and 19, three 
copies of chromosome X, and two copies each of chromosomes 17 and 18.  
 
Figure 3 
(A) FISH probe set III (see Table 2) hybridized on one normal male interphase nucleus (RGB 
colors). (B) The corresponding classified image from SKY system (pseudo-colors) showed 
two copies each of chromosomes 2, 3, 4, 5, and 12. The chromosome 9-Cy5.5 probe 
developed in-house showed weak hybridization signals and was not detected by the SKY 
system. (C) FISH probe set IV (see Table 2) hybridized on one normal male interphase 
nucleus (RGB colors). (D) The corresponding classified image from SKY system (pseudo-
colors) showed two copies each of chromosomes 1, 6, 7, 8, 10, and 11. The size bar on panel 
A indicates 2.5 µm and is representative of all panels. 
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